GlassScriptPhysician profile
Clare E Cormier
NPI 1538621362
$10,683.54
in general payments reported to CMS, 2019-2025
16 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,993 · 2023: $2,653 · 2024: $1,510 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195 · Travel and Lodging: $1,730 · Long Term Medical Supply Or Device Loan: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.64 |
| Travel and Lodging | $1,729.62 |
| Long Term Medical Supply Or Device Loan | $766.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,288.60 | 2022-2024 | Prostep, Ortholoc 2 Lapifuse, Prophecy |
| Medwest Associates | $1,214.97 | 2022 | |
| Crossroads Orthopedics, LLC | $1,200.00 | 2022 | |
| Integra Lifesciences Corporation | $1,053.23 | 2022-2024 | Acell, Integra, Primatrix |
| Arthrex, INC. | $897.92 | 2023 | |
| Trilliant Surgical LLC. | $851.44 | 2022 | |
| Depuy Synthes Sales INC. | $357.12 | 2022-2025 | Hammerlock, Tfn-Advance, Motoband |
| Medline Industries LP | $248.02 | 2024-2025 | |
| Flower Orthopedics Coporation | $242.00 | 2025 | |
| Acera Surgical, INC. | $117.34 | 2022 | |
| Angiodynamics, INC. | $54.00 | 2024 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $52.79 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $47.17 | 2023-2024 | Puraply |
| Treace Medical Concepts, INC. | $27.63 | 2025 | |
| Paragon 28, INC. | $16.25 | 2023 | Gorilla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.06 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Cormier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.